MARFLOXIN 100 MG/ML SOLUTION FOR INJECTION FOR CATTLE AND PIGS
Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Súhrn charakteristických
(SPC)
05-11-2016
Niektoré dokumenty týkajúce sa tohto produktu nie sú momentálne k dispozícii, môžete poslať požiadavku na náš zákaznícky servis a my vás upozorníme hneď, ako ich dokážeme získať.
Poslať žiadosť.
Poslať žiadosť.
Aktívna zložka:
MARBOFLOXACIN
Dostupné z:
Krka, d.d., Novo mesto
ATC kód:
QJ01MA93
INN (Medzinárodný Name):
MARBOFLOXACIN
Dávkovanie:
100 Mg/Ml
Forma lieku:
Solution for Injection
Typ predpisu:
POM
Terapeutické skupiny:
Bovine, Porcine
Terapeutické oblasti:
Marbofloxacin
Terapeutické indikácie:
Antibacterial
Stav Autorizácia:
Authorised
Dátum Autorizácia:
2011-08-26
Súhrn charakteristických
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Marfloxin 100 mg/ml solution for injection for cattle and pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Marbofloxacin
100 mg
EXCIPIENTS:
Disodium edetate
0.10 mg
Monothioglycerol
1 mg
Metacresol
2 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, greenish yellow to brownish yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cattle:
- treatment of respiratory infections caused by sensitive strains of _Pasteurella multocida, Mannheimia haemolytica _and
_Histophilus somni._
- treatment of acute _E.coli _mastitis_._
In pigs:
- treatment of Metritis Mastitis Agalactia (MMA) syndrome caused by susceptible strains of organisms.
4.3 CONTRAINDICATIONS
Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance).
Do not administer in animals with known hypersensitivity to fluoroquinolones, or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 21/10/2016_
_CRN 7022043_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones
should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond
poorly, to other classes of antimicrobials. Whenever possible, fluoroquinolones should only be used based on
susceptibility testing. Use of the product deviating
Prečítajte si celý dokument
